1. Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency
    Zikuan Song et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  2. An in-silico approach to understand the potential role of Wnt inhibitory factor-1 (WIF-1) in the inhibition of the Wnt signalling pathway
    Plaboni Sen et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
  3. Rapamycin-induced autophagy in osteosarcoma cells is mediated via the biglycan/Wnt/β-catenin signaling axis
    Eirini-Maria Giatagana et al, 2022, American Journal of Physiology-Cell Physiology CrossRef
  4. Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
    Xuetong Shen et al, 2023, Frontiers in Pharmacology CrossRef
  5. Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
    Maliheh Entezari et al, 2024, Current Cancer Drug Targets CrossRef
  6. The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer
    Zhijun Shen et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  7. Cytotoxic effect of Ziziphus Spina-Christi extract alone and in combination with doxorubicin on breast cancer cells
    null null et al, 2023, The Ukrainian Biochemical Journal CrossRef
  8. Long Non-coding RNA TDRKH-AS1 Promotes Colorectal Cancer Cell Proliferation and Invasion Through the β-Catenin Activated Wnt Signaling Pathway
    Yang Jiao et al, 2020, Frontiers in Oncology CrossRef
  9. Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning
    Carlos Pérez-Plasencia et al, 2020, Frontiers in Oncology CrossRef
  10. Wnts and the hallmarks of cancer
    Zheng Zhong et al, 2020, Cancer and Metastasis Reviews CrossRef
  11. Construction and Validation of an Autophagy-Related Prognostic Model for Osteosarcoma Patients
    Hu Qian et al, 2021, Journal of Oncology CrossRef
  12. Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 Expression
    Weilei Hu et al, 2020, Cancers CrossRef